The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Metastatic Colorectal Cancer Surgery-Global Market Insights and Sales Trends 2024
Synopsis
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Surgery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metastatic Colorectal Cancer Surgery in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers,, are propelling Metastatic Colorectal Cancer Surgery market. Tumor Resection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Portal Vein Embolization segment is estimated at % CAGR for the next seven-year period.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metastatic Colorectal Cancer Surgery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metastatic Colorectal Cancer Surgery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metastatic Colorectal Cancer Surgery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metastatic Colorectal Cancer Surgery covered in this report include Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech and EMD Serono, etc.
The global Metastatic Colorectal Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Global Metastatic Colorectal Cancer Surgery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metastatic Colorectal Cancer Surgery market, Segment by Type:
Tumor Resection
Portal Vein Embolization
Global Metastatic Colorectal Cancer Surgery market, by Application
Hospitals
Clinics
Cancer Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metastatic Colorectal Cancer Surgery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
The global Metastatic Colorectal Cancer Surgery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Metastatic Colorectal Cancer Surgery in various end use industries. The expanding demands from the Hospitals, Clinics and Cancer Research Centers,, are propelling Metastatic Colorectal Cancer Surgery market. Tumor Resection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Portal Vein Embolization segment is estimated at % CAGR for the next seven-year period.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Metastatic Colorectal Cancer Surgery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Metastatic Colorectal Cancer Surgery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Metastatic Colorectal Cancer Surgery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Metastatic Colorectal Cancer Surgery covered in this report include Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech and EMD Serono, etc.
The global Metastatic Colorectal Cancer Surgery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Global Metastatic Colorectal Cancer Surgery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Metastatic Colorectal Cancer Surgery market, Segment by Type:
Tumor Resection
Portal Vein Embolization
Global Metastatic Colorectal Cancer Surgery market, by Application
Hospitals
Clinics
Cancer Research Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Metastatic Colorectal Cancer Surgery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Metastatic Colorectal Cancer Surgery
1.1 Metastatic Colorectal Cancer Surgery Market Overview
1.1.1 Metastatic Colorectal Cancer Surgery Product Scope
1.1.2 Metastatic Colorectal Cancer Surgery Market Status and Outlook
1.2 Global Metastatic Colorectal Cancer Surgery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Metastatic Colorectal Cancer Surgery Market Size by Region (2018-2029)
1.4 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Region (2018-2023)
1.5 Global Metastatic Colorectal Cancer Surgery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.1 North America Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.2 Europe Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.4 Latin America Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
1.6.5 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size (2018-2029)
2 Metastatic Colorectal Cancer Surgery Market by Type
2.1 Introduction
2.1.1 Tumor Resection
2.1.2 Portal Vein Embolization
2.2 Global Metastatic Colorectal Cancer Surgery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Type (2018-2023)
2.2.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Metastatic Colorectal Cancer Surgery Revenue Breakdown by Type (2018-2029)
3 Metastatic Colorectal Cancer Surgery Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Cancer Research Centers
3.2 Global Metastatic Colorectal Cancer Surgery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Metastatic Colorectal Cancer Surgery Historic Market Size by Application (2018-2023)
3.2.2 Global Metastatic Colorectal Cancer Surgery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Metastatic Colorectal Cancer Surgery Revenue Breakdown by Application (2018-2029)
4 Metastatic Colorectal Cancer Surgery Competition Analysis by Players
4.1 Global Metastatic Colorectal Cancer Surgery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Metastatic Colorectal Cancer Surgery as of 2022)
4.3 Date of Key Players Enter into Metastatic Colorectal Cancer Surgery Market
4.4 Global Top Players Metastatic Colorectal Cancer Surgery Headquarters and Area Served
4.5 Key Players Metastatic Colorectal Cancer Surgery Product Solution and Service
4.6 Competitive Status
4.6.1 Metastatic Colorectal Cancer Surgery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.1.4 Sanofi Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.1.5 Sanofi Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.2.4 Roche Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Profile
5.3.2 Eli Lilly Main Business
5.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.3.4 Eli Lilly Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.4.4 Pfizer Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.5.4 Novartis Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.5.5 Novartis Recent Developments
5.6 Amgen
5.6.1 Amgen Profile
5.6.2 Amgen Main Business
5.6.3 Amgen Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.6.4 Amgen Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.6.5 Amgen Recent Developments
5.7 Taiho Oncology
5.7.1 Taiho Oncology Profile
5.7.2 Taiho Oncology Main Business
5.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.7.4 Taiho Oncology Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.7.5 Taiho Oncology Recent Developments
5.8 Genentech
5.8.1 Genentech Profile
5.8.2 Genentech Main Business
5.8.3 Genentech Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.8.4 Genentech Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.8.5 Genentech Recent Developments
5.9 EMD Serono
5.9.1 EMD Serono Profile
5.9.2 EMD Serono Main Business
5.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.9.4 EMD Serono Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.9.5 EMD Serono Recent Developments
5.10 Suzhou Zelgen Biopharmaceuticals
5.10.1 Suzhou Zelgen Biopharmaceuticals Profile
5.10.2 Suzhou Zelgen Biopharmaceuticals Main Business
5.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Products, Services and Solutions
5.10.4 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Revenue (US$ Million) & (2018-2023)
5.10.5 Suzhou Zelgen Biopharmaceuticals Recent Developments
6 North America
6.1 North America Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Metastatic Colorectal Cancer Surgery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Metastatic Colorectal Cancer Surgery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Metastatic Colorectal Cancer Surgery Market Dynamics
11.1 Metastatic Colorectal Cancer Surgery Industry Trends
11.2 Metastatic Colorectal Cancer Surgery Market Drivers
11.3 Metastatic Colorectal Cancer Surgery Market Challenges
11.4 Metastatic Colorectal Cancer Surgery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
